+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alanine Aminotransferase"

From
2020 ALT/SGPT Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 ALT/SGPT Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
2021 ALT/SGPT Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2021 ALT/SGPT Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2021
  • Japan, United States, ... Japan, United States, Europe
From
  • 12 Results (Page 1 of 1)
Loading Indicator

The Alanine Aminotransferase (ALT) market within the In Vitro Diagnostics (IVD) industry is a segment of the larger IVD market. ALT is an enzyme found in the liver and is used to diagnose liver diseases. ALT tests are used to detect and monitor liver damage, as well as to monitor the effectiveness of treatments. ALT tests are also used to diagnose and monitor other conditions, such as diabetes, heart disease, and cancer. ALT tests are typically performed in a laboratory setting, using a variety of methods, such as enzyme-linked immunosorbent assays (ELISA), spectrophotometry, and immunoassays. The ALT market is expected to grow due to the increasing prevalence of liver diseases, as well as the increasing demand for accurate and reliable diagnostic tests. Some of the major companies in the ALT market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Bio-Rad Laboratories, and Ortho Clinical Diagnostics. Show Less Read more